Healthcare in Europe is driven by world‑class research, advanced technologies, and high standards of care—but progress is often slowed by small population sizes, challenges launching new clinical trials, and limited funding for international collaboration.
The Precision Medicine Forum – Stockholm brings together leaders from healthcare, research, policy, and industry to address these barriers and accelerate the future of precision medicine. As a sponsor, biomodal is proud to be part of this critical conversation.
🎤 Join biomodal’s talk with Leonardo Motta to discover how our next‑generation multiomic technologies bring clarity to complex biology. In this talk, Leonardo will showcase duet™ cfDNA, a fully integrated genetic and epigenetic workflow designed specifically for low‑input cfDNA applications. By capturing a complete set of biomarkers—including genetic variants, 5mC and 5hmC, and fragmentomic information—from every DNA fragment, duet™ cfDNA delivers ultra‑low limits of detection for ctDNA.
With market‑leading 6‑base accuracy, this approach has been shown to detect cancer earlier than other methylation‑based methods and to provide deeper insight into treatment response in clinical trials—unlocking a more complete view of disease biology from a single sample.
👉 Want to connect at the Forum – or sooner? Schedule time with Leonardo by completing the form below and let’s start the conversation.
